Biotech · Private company
Kissei Pharmaceutical Co., Ltd.
Track this companyFree. Adds Kissei Pharmaceutical Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- 200 mg linzagolix tabletPhase 3 · EndometriosisClinicalTrials.gov · fetched Nov 12, 2026
- 75 mg linzagolix tabletPhase 3 · EndometriosisClinicalTrials.gov · fetched Nov 12, 2026
- Add-back capsule (E2 1 mg / NETA 0.5 mg)Phase 3 · EndometriosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated PainPHASE3 · TERMINATED · started Mar 23, 2020ClinicalTrials.gov NCT04372121 · fetched Nov 12, 2026
- Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6)PHASE3 · COMPLETED · started Mar 5, 2020ClinicalTrials.gov NCT04335591 · fetched Nov 12, 2026
- Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.PHASE3 · COMPLETED · started Jun 13, 2019ClinicalTrials.gov NCT03992846 · fetched Nov 12, 2026
- A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated PainPHASE3 · TERMINATED · started May 23, 2019ClinicalTrials.gov NCT03986944 · fetched Nov 12, 2026